Tanvex BioPharma, Inc.

Company Profile

Sector

Healthcare

Industry

Biotechnology

Employees

215

Website

www.tanvex.com

Country

Cayman Islands

Exchange

Taiwan

Founded 2011George Town

Tanvex BioPharma, Inc., a pharmaceutical company develops, manufactures, and sells biosimilar products in Taiwan and the United States. The company focuses on delivering biopharmaceuticals with biosimilars targeting neutropenia, breast cancer, metastatic colorectal cancer, and psoriasis Contract development and manufacturing of biological medicines. Founded in 2011, the company is headquartered in George Town, the Cayman Islands.

Key Stats

52-Week Range

NT$37.25NT$68.00

Beta0.21

Trailing P/EN/A

Forward P/E-9.96

Trailing EPS-6.13

Avg Volume

Earnings & Analyst

Next EarningsN/A

EPS EstimateN/A

Target Mean PriceN/A

RecommendationNone

Recommendation MeanN/A

Recent SEC Filings

SEC filings for this ticker are not available yet.